Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/15087
Title: | Systemic treatment with the inhibitory neurotransmitter gamma-aminobutyric acid aggravates experimental autoimmune encephalomyelitis by affecting proinflammatory immune responses | Authors: | CARMANS, Sofie HENDRIKS, Jerome Slaets, Helena THEWISSEN, Kristof STINISSEN, Piet RIGO, Jean-Michel HELLINGS, Niels |
Issue Date: | 2013 | Publisher: | ELSEVIER SCIENCE BV | Source: | JOURNAL OF NEUROIMMUNOLOGY, 255 (1-2), p. 45-53 | Abstract: | Transcriptomic and proteomic analyses of multiple sclerosis (MS) lesions indicate alterations in the gamma-aminobutyric acid (GABA) inhibitory system, suggesting its involvement in the disease process. To further elucidate the role of GABA in central nervous system (CNS) inflammation in vivo, the chronic myelin oligodendrocyte glycoprotein (MOG)(35-55) experimental autoimmune encephalomyelitis (EAE) model was used. Daily GABA injections (200 mg/kg) from day 3 onwards significantly augmented disease severity, which was associated with increased CNS mRNA expression levels of tumor necrosis factor alpha (TNF-alpha) and interleukin (IL)-6. GABA-treated mice showed enhanced MUG-dependent proliferation and were skewed towards a T helper 1 phenotype. Moreover, in vitro, the lipopolysaccharide (LPS)-induced increase in interleukin (IL)-6 production by macrophages was enhanced at low GABA concentrations (0.03-0.3 mM). In sharp contrast to exogenous GABA administration, endogenous GABA increment by systemic treatment with the GABA-transaminase inhibitor vigabatrin (250 mg/kg) had prophylactic as well as therapeutic potential in EAE. Together, these results indicate an immune amplifying role of GABA in neuroinflammatory diseases like MS. | Notes: | [Carmans, Sofie; Hendriks, Jerome J. A.; Slaets, Helena; Thewissen, Kristof; Stinissen, Piet; Rigo, Jean-Michel; Hellings, Niels] Hasselt Univ, Biomed Res Inst, B-3590 Diepenbeek, Belgium. | Keywords: | Immunology; Neurosciences; multiple sclerosis; experimental autoimmune encephalomyelitis; gammo-amino butyric acid; vigabatrin; macrophage; T cell;Multiple sclerosis; Experimental autoimmune encephalomyelitis; Gamma amino-butyric acid; Vigabatrin, macrophage, T cell | Document URI: | http://hdl.handle.net/1942/15087 | ISSN: | 0165-5728 | e-ISSN: | 1872-8421 | DOI: | 10.1016/j.jneuroim.2012.11.001 | ISI #: | 000315014700006 | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2014 |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
systemic treatment.pdf Restricted Access | 982.73 kB | Adobe PDF | View/Open Request a copy |
SCOPUSTM
Citations
24
checked on Sep 2, 2020
WEB OF SCIENCETM
Citations
29
checked on Oct 14, 2024
Page view(s)
78
checked on Apr 26, 2023
Download(s)
50
checked on Apr 26, 2023
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.